Association Between Patient-Centered Medical Homes and Adherence to Chronic Disease Medications: A Cohort Study
Overview
Authors
Affiliations
Background: Despite the widespread adoption of patient-centered medical homes into primary care practice, the evidence supporting their effect on health care outcomes has come primarily from geographically localized and well-integrated health systems.
Objective: To assess the association between medication adherence and medical homes in a national patient and provider population, given the strong ties between adherence to chronic disease medications and health care quality and spending.
Design: Retrospective cohort study.
Setting: Claims from a large national health insurer.
Patients: Patients initiating therapy with common medications for chronic diseases (diabetes, hypertension, and hyperlipidemia) between 2011 and 2013.
Measurements: Medication adherence in the 12 months after treatment initiation was compared among patients cared for by providers practicing in National Committee for Quality Assurance-recognized patient-centered medical homes and propensity score-matched control practices in the same Primary Care Service Areas. Linear mixed models were used to examine the association between medical homes and adherence.
Results: Of 313 765 patients meeting study criteria, 18 611 (5.9%) received care in patient-centered medical homes. Mean rates of adherence were 64% among medical home patients and 59% among control patients. Among 4660 matched control and medical home practices, medication adherence was significantly higher in medical homes (2.2% [95% CI, 1.5% to 2.9%]). The association between medical homes and better adherence did not differ significantly by disease state (diabetes, 3.0% [CI, 1.5% to 4.6%]; hypertension, 3.2% [CI, 2.2% to 4.2%]; hyperlipidemia, 1.5% [CI, 0.6% to 2.5%]).
Limitation: Clinical outcomes related to medication adherence were not assessed.
Conclusion: Receipt of care in a patient-centered medical home is associated with better adherence, a vital measure of health care quality, among patients initiating treatment with medications for common high-cost chronic diseases.
Primary Funding Source: CVS Health.
Tong X, Zou H, Zhang L, Chen W BMC Public Health. 2025; 25(1):404.
PMID: 39891108 PMC: 11786533. DOI: 10.1186/s12889-025-21656-0.
Mo H, Zhong R, Ma F Cancer Innov. 2024; 3(5):e137.
PMID: 39081932 PMC: 11287348. DOI: 10.1002/cai2.137.
Costs of Prescription Drugs for Children and Parental Adherence to Long-Term Medications.
Lauffenburger J, Barlev R, Olatunji E, Brill G, Choudhry N JAMA Netw Open. 2023; 6(10):e2337971.
PMID: 37843860 PMC: 10580109. DOI: 10.1001/jamanetworkopen.2023.37971.
Liu Z, Feng J, Fang Y, Cheng Y, Li S Orphanet J Rare Dis. 2023; 18(1):226.
PMID: 37537616 PMC: 10398971. DOI: 10.1186/s13023-023-02838-8.
Medication Adherence in American Indians With Type 2 Diabetes: An Integrative Review.
Nelson T, Wilkie D, Scarton L Diabetes Spectr. 2023; 36(2):193-200.
PMID: 37193204 PMC: 10182960. DOI: 10.2337/ds21-0096.